Dr. Stephanie Eid reviews the current state of our understanding of how type 2 diabetes damages the nerve, retina and kidney in patients, and how this damage may be secondary to high blood levels of lipids.
Dr. Eva Feldman joined Detroit Public Television's Colleen O'Donnell on Facebook Live in advance of the airing of "Collateral Damage," a documentary about ALS in which she was featured.
Former members of Michigan Wolverine basketball joined the ALS Center of Excellence for Hoops Fight ALS—a program of events to raise money for the University of Michigan's ALS clinic and its research.
A blood test for Alzheimer’s disease – what benefit does early detection hold without a cure?
Awarded at the 2019 PNS Annual Meeting in Genoa Italy, the Gebhart Prize recognizes Dr. Feldman’s contributions to the PNS mission: supporting research, training scientists, setting standards of care, creating new treatments, and facilitating clinical trials. Ten PNR&D scientists and staff attended and presented at the conference.
Jon Gerych, Jim Hiller, Lisa Rosenberg and Dr. Brian Roth have joined the U-M ALS Center of Excellence National Advisory Board. Their addition brings the total number of board members to 16.
Dr. Brian Callaghan discussed his recent drug cost research on Michigan Radio's Stateside program. His research investigated the sharp rise in drug costs to patients suffering from neurologic diseases.
Recently published in Neurology , Dr. Brian Callaghan (right) contends that neurologists have a duty to their patients to consider financial burdens when prescribing medications.
Research from Drs. Sarah Elzinga, Stephanie Eid and Kai Guo shows that the activity of the genes with which you are born can be changed during your lifetime by the environment and by chronic diseases, such as type 2 diabetes.
PNR&D is hosting its second visiting scholar, Mohamed El Massry, who is spending five weeks this spring in the aboratory to learn how to assess nerve structure and function in diabetes.
Dr. Eva Feldman was the keynote speaker at the Susan Mast<br>ALS Foundation Luncheon on May 20 in Grand Rapids,<br>Michigan.
Dr. Eva Feldman, Director of the ALS Center of Excellence at Michigan Medicine, joined Sherry Schuen and Catie Matzka to discuss ALS on WGVU with host Shelley Irwin.
PNR&D collaboraters Ahmed Ali, M.D., and John Hanks, M.D., received first prize from the Triological Society for their poster at the 2019 Combined Otolaryngology Spring Meeting.
Dr. Stephen Goutman, clinical director of the ALS Center of Excellence, threw out the ceremonial first pitch at the University of Michigan baseball team's inaugural ALS Awareness Game on May 7.
Recently published in Neurology , Dr. Brian Callaghan (right) contends that neurologists have a duty to their patients to consider financial burdens when prescribing medications.
The University of Michigan baseball team will host rival Michigan State on May 7 at 6 p.m. in the inaugural Strikeout ALS Game, presented by Michigan Medicine’s ALS Center of Excellence.
After losing her mother to Alzheimer's disease, Dr. Eva Feldman has led the way in developing new stem cell treatments.
Michigan Medicine researchers identify a potential therapeutic target for neurodegenerative conditions using models.
Dr. Stephen Goutman reviewed his recent ALS research on<br> Michigan Radio’s Stateside program. His latest findings<br> examined how environmental toxins impact ALS progression.
In a new study, lead author Dr. Amy Rumora and senior author Dr. Eva Feldman observed a reversal of chronic nerve damage with the consumption of unsaturated dietary fats.
